Amlodipine Besylate Tablet
Product Images NDC 0480-0083

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 0480-0083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure diagram of Amlodipine Besylate, showing its molecular framework and chemical formula C20H25ClN2O5.*
FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig01.jpg)

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig01.jpg)
A Kaplan-Meier curve graph comparing event rates over time in months for Amlodipine versus placebo. The graph shows cumulative event rates with separate lines for Amlodipine and placebo groups, including p-value, hazard ratio, and confidence interval in the inset box. The x-axis represents time in months, and the y-axis represents event rate.*
FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig02.jpg)

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig02.jpg)
A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across various patient subgroups, including overall, age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis ranges from 0.0 to 2.0, indicating relative risk levels favoring Amlodipine or placebo.*
FDA Label Image

Cl 2.5 mg, 90s (Image 4)

Cl 2.5 mg, 90s (Image 4)
Amlodipine Besylate Tablets, USP 2.5 mg oral tablets packaging label from Teva Pharmaceuticals, Inc., containing 90 tablets. The label includes NDC 0480-0083-98, storage instructions at 20 to 25°C, and a pharmacist notice to dispense with the patient information leaflet. Manufactured by Teva Pharmaceutical Industries Ltd.*
FDA Label Image

Cl 5 mg, 90s (Image 5)

Cl 5 mg, 90s (Image 5)
Amlodipine Besylate Tablets, USP 5 mg oral tablets label from Teva Pharmaceuticals, Inc. The label indicates a package of 90 tablets with instructions to dispense with an attached patient information leaflet. Storage instructions and manufacturer details are also included.*
FDA Label Image

Cl 10 mg, 90s (Image 6)

Cl 10 mg, 90s (Image 6)
A rectangular label for Amlodipine Besylate Tablets, USP 10 mg by Teva Pharmaceuticals, Inc. The label includes dosage strength, warning instructions for pharmacists to dispense with patient information leaflet, quantity of 90 tablets, storage instructions, and manufacturer details. The Teva logo appears in the bottom right corner.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.